{
    "organizations": [],
    "uuid": "3d105e7ebb939b12bf6a21fe86fa905bb7001fa3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-emergent-biosolutions-awarded-one/brief-emergent-biosolutions-awarded-one-year-cdc-contract-valued-at-26-mln-idUSFWN1QI0TG",
    "ord_in_thread": 0,
    "title": "BRIEF-Emergent Biosolutions Awarded One-Year CDC Contract Valued At $26 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Emergent Biosolutions Inc:\n* EMERGENT BIOSOLUTIONS AWARDED ONE-YEAR CDC CONTRACT VALUED AT $26 MILLION FOR VACCINIA IMMUNE GLOBULIN PROGRAM\n* EMERGENT - UNDER AWARD, WILL CONDUCT MANUFACTURING RUNS, COLLECT PLASMA, UNDERTAKE ADDITIONAL ACTIVITIES FOR MAINTAINING VIGIVâ€˜S FDA LICESNSURE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-28T19:55:00.000+02:00",
    "crawled": "2018-03-01T21:24:43.027+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "emergent",
        "biosolutions",
        "inc",
        "emergent",
        "biosolutions",
        "awarded",
        "cdc",
        "contract",
        "valued",
        "million",
        "vaccinia",
        "immune",
        "globulin",
        "program",
        "emergent",
        "award",
        "conduct",
        "manufacturing",
        "run",
        "collect",
        "plasma",
        "undertake",
        "additional",
        "activity",
        "maintaining",
        "vigiv",
        "fda",
        "licesnsure",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}